Page de couverture de Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Auteur(s): Annenberg Center for Health Sciences
Écouter gratuitement

À propos de cet audio

 Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.Annenberg Center for Health Sciences Hygiène et mode de vie sain Troubles et maladies
Épisodes
  • Introduction and Key Takeaways

    Introduction and Key Takeaways
    Oct 7 2024

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
    Voir plus Voir moins
    15 min
Pas encore de commentaire